Lebwohl, Mark, Bruce Strober, Amy Schrader, Alvin Li, Thomas Eckmann, Baojin Zhu, William Malatestinic, Julie Birt, Meghan Feely, and Andrew Blauvelt. 2023. “6-Month Real World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry”. SKIN The Journal of Cutaneous Medicine 7 (6):s232. https://doi.org/10.25251/skin.7.supp.232.